|
IQVIA™ Real-World Insights Bibliography
| The emerging role of real-world data in advanced breast cancer therapy: Recommendations for collaborative decision-making
|
| Author(s): Paul Cottu 1, Scott David Ramsey 2, Oriol Solà-Morales 3, Patricia A Spears 4, Lockwood Taylor 5 |
| Affiliations(s): 1Department of Medical Oncology, Institut Curie, 26 Rue D'Ulm, 75005, Paris, France. Electronic address: paul.cottu@curie.fr.
2Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North, M2-B232, Seattle, WA, 98155, USA. Electronic address: sramsey@fredhutch.org.
3Health Innovation Technology Transfer Foundation, Aragó 60, E-08015, Barcelona, Spain. Electronic address: osola@fhitt.org.
48605 Carolingian Court, Raleigh, NC, 27615, USA. Electronic address: paspears88@gmail.com.
5Epidemiology, Real World Solutions at IQVIA, 4820 Emperor Boulevard, Durham, NC, 27703, USA. Electronic address: lockwood.taylor@iqvia.com. |
Publication(s): Breast. 2021 Dec 22;61:118-122. doi: 10.1016/j.breast.2021.12.015.
|
| Document Type(s): Article, |
| Countries: France, Italy, USA, |
| Click here for the abstract |
C:
Y: |
Comparative Effectiveness & Health Technology Assessment, Drug safety, Oncology, Regulatory,
2022 |
|
L:
A: |
English
Review, |
|
 |
| |
| |
| Burden of Hospitalizations and Outpatient Visits Associated With Moderate and Severe Acute Graft-Versus-Host Disease in Finland and Sweden: A Real-World Data Analysis |
| Author(s): Lorenzo Sabatelli, PhD,1 Mikko Keränen, MD, PhD,2 Elisabet Viayna, PhD,3 Montserrat Roset, BSc Stats,3 Nuria Lara, MD, MSc,3 Daniel Thunström, MSc Pharm,1 Minja Pfeiffer, PhD,1 Malin Nicklasson, MSc Pharm,4 Maija Itälä-Remes, MD, PhD5
|
| Affiliations(s): "1Incyte Biosciences International Sàrl, Morges, Switzerland; 2Helsinki University Hospital, Helsinki, Finland; 3IQVIA Real World Solutions, Barcelona, Spain; 4Department of Hematology and Coagulation, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 5Turku University Hospital, Turku, Finland "
|
Publication(s): Supportive Care in Cancer
|
| Document Type(s): Article, |
| Countries: Finland, Spain, Sweden, Switzerland, |
C:
Y: |
Health economics, Transplant,
2022 |
|
L:
A: |
English
Clinical setting: hospital, Observational study, Population Based Study, |
|
|
| |
| |
| Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study
|
| Author(s): "Kerstin M G Brand, Laura Saarelainen, Jaak Sonajalg, Emmanuelle Boutmy, Caroline Foch, Marja Vääräsmäki, Laure Morin-Papunen, Judith Schlachter, CLUE Study Group, Katja M Hakkarainen, Pasi Korhonen
CLUE Study Group: Minna Vehkala, Robyn Thorén, Henrik Svanström "
|
| Affiliations(s): "Leading author: Kerstin Brand: Merck KGaA, Darmstadt, Germany
IQVIA author affiliations: Global Database Studies, IQVIA, Espoo, Finland; Global Database Studies, IQVIA, Tartu, Estonia; Global Database Studies, IQVIA, Solna, Sweden; Global Database Studies, IQVIA"
|
Publication(s): BMJ Open Diab Res Care 2022;10:e002363. doi:10.1136/bmjdrc-2021-002363
|
| Document Type(s): Article, |
| Countries: Finland, |
| Click here for the abstract |
C:
Y: |
Diabetes, Obesity,
2022 |
|
L:
A: |
English
Clinical setting: Primary care, clinical setting: Secondary care, Epidemiological study, Population Based Study, Retrospective cohort analysis, |
|
|
| |
| |
| Real-world persistence of erenumab for preventive treatment of chronic and episodic migraine: Retrospective real-world study
|
| Author(s): Jonathan Gladstone 1, Sameer Chhibber 2, Jagdeep Minhas 3, Calum S Neish 3, G Sarah Power 3, Zhiyi Lan 3, Driss Rochdi 4, Jessica Lanthier-Martel 4, Natacha Bastien 4 |
| Affiliations(s): 1Neurology, Cleveland Clinic Canada, Toronto, Ontario, Canada.
2Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
3Real-world Solutions, IQVIA, Kirkland, Québec, Canada.
4Neuroscience, Novartis Pharmaceuticals Canada Inc., Dorval, Québec, Canada. |
Publication(s): Headache The Journal of Head and Face Pain
PMID: 34807454 DOI: 10.1111/head.14218
|
| Document Type(s): Article, |
| Countries: Canada, |
| Click here for the abstract |
C:
Y: |
Health status & patient reported outcomes,
2022 |
|
L:
A: |
English
Clinical setting: Primary care, direct to patient research, |
|
|
| |
| |
| Real-world 12-month Retention on Secukinumab Among Axial Spondyloarthritis Patients within the Canadaian Spondyloarthritis (CanSpA) Research Network
|
| Author(s): Dr. Robert Inman, Dr. Denis Choquette, Dr. Majed Khraishi, Dr. Dafna Gladman, Shamiza Hussein, Drew Neish, Patrick Leclerc
|
| Affiliations(s): Robert Inman (Toronto Western Hospital, Toronto); Denis Choquette (Institut de Rhumatologie
de Montréal, Montréal); Majed Khraishi (Department of Medicine, Memorial University of
Newfoundland, St. John's); Dafna Gladman (Krembil Research Institute, Toronto Western
Hospital, Toronto); Shamiza Hussein (Novartis, Montreal); Drew Neish (IQVIA, Montreal);
Patrick Leclerc (Novartis Canada, Montreal) |
| Publication(s): |
| Document Type(s): Poster, |
| Countries: Canada, |
| Click here for the abstract |
C:
Y: |
Clinical practice,
2022 |
|
L:
A: |
English
Clinical setting: hospital, |
|
|
| |
| |
| Concomitant Medication Use in the Treatment Journey of Pulmonary Arterial Hypertension Patients:
A Canadian Retrospective Claims Analysis |
| Author(s): Essam Ibrahim1, Assem Al-Akabawi1, Moses Dawodu1, Juejing Ling2, Irene Wang2, Brad Millson3 |
| Affiliations(s): 1Janssen Canada Inc, Toronto, ON, Canada; 2IQVIA Solutions Canada Inc., Mississauga, ON, Canada; 3IQVIA Solutions Canada Inc., Kanata, ON, Canada |
| Publication(s): |
| Document Type(s): Poster, |
| Countries: Canada, |
C:
Y: |
Endocrinology,
2022 |
|
L:
A: |
English
Clinical setting: hospital, Clinical setting: Primary care, direct to patient research, Observational study, |
|
|
| |
| |
| Real-World Drug Retention and Initiation of Combination Drug Therapy for Patients with Pulmonary Arterial
Hypertension in Canada: A Retrospective Prescription Claims Database Study |
| Author(s): Essam Ibrahim1, Assem Al-Akabawi1, Moses Dawodu1, Juejing Ling2, Jillian Murray2, Brad Millson3 |
| Affiliations(s): 1Janssen Canada Inc, Toronto, ON, Canada; 2IQVIA Solutions Canada Inc., Mississauga, ON, Canada; 3IQVIA Solutions Canada Inc., Kanata, ON, Canada |
Publication(s): IQVIA Canadian Private Drug Plan (PDP) databases
|
| Document Type(s): Poster, |
| Countries: Canada, |
C:
Y: |
2022 |
|
L:
A: |
English
direct to patient research, |
|
|
| |
| |
| Georgraphic Variation in the Use of Gabapentinoids and Opioids for Pain in a Commercially Insured Adult Population in the United States |
| Author(s): Danni Zhao, Jonggyu Baek, Anne L Hume, Emily A McPhillips, and Kate L Lapane
|
| Affiliations(s): 1Department of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, MA, USA.
2Department of Family Medicine, Alpert Medical School, Brown University, Memorial Hospital of Rhode Island, Providence, RI, USA.
3Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, RI, USA. |
Publication(s): J Pain Res
. 2022 Feb 11;15:443-454. doi: 10.2147/JPR.S345521. eCollection 2022.
|
| Document Type(s): Article, |
| Countries: USA, |
| Click here for the abstract |
C:
Y: |
Drug Utlization Study, Pain,
2022 |
|
L:
A: |
English
Epidemiological study, Observational study, Public Health, |
|
|
| |
| |
| Health-related quality of life in patients with alopecia areata: Results of a Japanese survey with norm-based comparisons |
| Author(s): Taisuke Ito 1, Kazumasa Kamei 2, Akira Yuasa 3, Fumihiro Matsumoto 2, Yayoi Hoshi 4, Masafumi Okada 4, Shinichi Noto 5 (rwesheorj 4) |
| Affiliations(s): 1) Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan
2) Inflammation and Immunology Medical Affairs, Pfizer Japan Inc., Tokyo, Japan
3) Health and Value, Pfizer Japan Inc., Tokyo, Japan
4) Real-World Evidence Solutions & HEOR, IQVIA Solutions Japan K.K., Tokyo, Japan |
Publication(s): The Journal of Dermatology
|
| Document Type(s): Online article, |
| Countries: Japan, |
| Click here for the abstract |
C:
Y: |
Dermatology, Mental health,
2022 |
|
L:
A: |
English
Patient questionnaire, Quality of life, Survey research, |
|
|
| |
| |
| A real-world, observational study of erenumab for migraine prevention in Canadian patients
|
| Author(s): Werner J Becker 1, Sian Spacey 2, Elizabeth Leroux 3, Rose Giammarco 4, Jonathan Gladstone 5, Suzanne Christie 6, Arash Akaberi 7, G Sarah Power 8, Jagdeep K Minhas 9, Johanna Mancini 7, Driss Rochdi 10, Ayca Filiz 10, Natacha Bastien 10 |
| Affiliations(s): 1Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
2Division of Neurology, University of British Columbia, Vancouver, British Columbia, Canada.
3Brunswick Medical Center, Montreal, Quebec, Canada.
4Hamilton Headache Clinic, Hamilton, Ontario, Canada.
5Gladstone Headache Clinic, Toronto, Ontario, Canada.
6Ottawa Headache Centre Inc., Ottawa, Ontario, Canada.
7IQVIA Solutions Canada Inc., Montreal, Quebec, Canada.
8IQVIA Solutions Canada Inc., Mississauga, Ontario, Canada.
9IQVIA Solutions Canada Inc., Ottawa, Ontario, Canada.
10Novartis Canada, Dorval, Quebec, Canada. |
Publication(s): Headache. 2022 Apr;62(4):522-529. doi: 10.1111/head.14291. Epub 2022 Apr 10. PMID: 35403223.
|
| Document Type(s): Article, |
| Countries: Canada, |
| Click here for the abstract |
C:
Y: |
Neurological disorders,
2022 |
|
L:
A: |
English
Observational study, |
|
|
| |
| |
 1 of 426 
|
|
